113 related articles for article (PubMed ID: 35116115)
1. Lnc524369 promotes hepatocellular carcinoma progression and predicts poor survival by activating YWHAZ-RAF1 signaling.
Zheng W; Shen GL; Xu KY; Yin QQ; Hui TC; Zhou ZW; Xu CA; Wang SH; Wu WH; Shi LF; Pan HY
World J Gastrointest Oncol; 2022 Jan; 14(1):253-264. PubMed ID: 35116115
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA MIR4435-2HG promotes hepatocellular carcinoma proliferation and metastasis through the miR-22-3p/YWHAZ axis.
Shen X; Ding Y; Lu F; Yuan H; Luan W
Am J Transl Res; 2020; 12(10):6381-6394. PubMed ID: 33194037
[TBL] [Abstract][Full Text] [Related]
3. miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.
Chen M; Hu W; Xiong CL; Qu Z; Yin CQ; Wang YH; Luo CL; Guan Q; Yuan CH; Wang FB
Oncotarget; 2016 Dec; 7(49):80751-80764. PubMed ID: 27811373
[TBL] [Abstract][Full Text] [Related]
4. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
Qin AD; Liu XX; Li J; Liu J; Li YS
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
[No Abstract] [Full Text] [Related]
5. The ASH1-miR-375-YWHAZ Signaling Axis Regulates Tumor Properties in Hepatocellular Carcinoma.
Zhao JF; Zhao Q; Hu H; Liao JZ; Lin JS; Xia C; Chang Y; Liu J; Guo AY; He XX
Mol Ther Nucleic Acids; 2018 Jun; 11():538-553. PubMed ID: 29858089
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
[No Abstract] [Full Text] [Related]
7. LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.
Liu J; Xu R; Mai SJ; Ma YS; Zhang MY; Cao PS; Weng NQ; Wang RQ; Cao D; Wei W; Guo RP; Zhang YJ; Xu L; Chen MS; Zhang HZ; Huang L; Fu D; Wang HY
Theranostics; 2020; 10(17):7527-7544. PubMed ID: 32685003
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA LINC01134 Promotes Hepatocellular Carcinoma Metastasis via Activating AKT1S1 and NF-κB Signaling.
Wang C; Chen Y; Chen K; Zhang L
Front Cell Dev Biol; 2020; 8():429. PubMed ID: 32656205
[TBL] [Abstract][Full Text] [Related]
9. A liver-specific lncRNA, FAM99B, suppresses hepatocellular carcinoma progression through inhibition of cell proliferation, migration, and invasion.
Mo M; Liu S; Ma X; Tan C; Wei L; Sheng Y; Song Y; Zeng X; Huang D; Qiu X
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2027-2038. PubMed ID: 31243545
[TBL] [Abstract][Full Text] [Related]
10. MiR-451a suppresses cell proliferation, metastasis and EMT via targeting YWHAZ in hepatocellular carcinoma.
Wei GY; Hu M; Zhao L; Guo WS
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5158-5167. PubMed ID: 31298411
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
12. KHDRBS3 accelerates glycolysis and promotes malignancy of hepatocellular carcinoma via upregulating 14-3-3ζ.
Zhao M; Zhang Y; Li L; Liu X; Zhou W; Wang C; Tang Y
Cancer Cell Int; 2023 Oct; 23(1):244. PubMed ID: 37848941
[TBL] [Abstract][Full Text] [Related]
13. Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway.
Sun J; Guo Y; Bie B; Zhu M; Tian H; Tian J; Li J; Yang Y; Ji F; Kong G; Li Z
J Cell Biochem; 2020 Jan; 121(1):443-457. PubMed ID: 31231887
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.
Wang JL; Yang MY; Xiao S; Sun B; Li YM; Yang LY
J Exp Clin Cancer Res; 2018 Mar; 37(1):45. PubMed ID: 29506567
[TBL] [Abstract][Full Text] [Related]
15. LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p/ARHGAP18 signaling axis.
Chen J; Huang X; Wang W; Xie H; Li J; Hu Z; Zheng Z; Li H; Teng L
Aging (Albany NY); 2018 Nov; 10(11):3371-3381. PubMed ID: 30510148
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of EGFL8 regulates migration, invasion and apoptosis of hepatocellular carcinoma through activating Notch signaling pathway.
Wu F; Zhang FY; Tan GQ; Chen WJ; Huang B; Yan L; Zhang HL; Chen S; Jiao Y; Wang BL
BMC Cancer; 2021 Jun; 21(1):704. PubMed ID: 34130659
[TBL] [Abstract][Full Text] [Related]
17. Upregulated long non-coding RNA LOC90784 promotes cell proliferation and invasion and is associated with poor clinical features in HCC.
Xu JH; Chang WH; Fu HW; Shu WQ; Yuan T; Chen P
Biochem Biophys Res Commun; 2017 Aug; 490(3):920-926. PubMed ID: 28651931
[TBL] [Abstract][Full Text] [Related]
18. LncRNA PCAT6 predicts poor prognosis in hepatocellular carcinoma and promotes proliferation through the regulation of cell cycle arrest and apoptosis.
Luo Y; Lin J; Zhang Y; Dai G; Li A; Liu X
Cell Biochem Funct; 2020 Oct; 38(7):895-904. PubMed ID: 32064636
[TBL] [Abstract][Full Text] [Related]
19. ITGB1 Drives Hepatocellular Carcinoma Progression by Modulating Cell Cycle Process Through PXN/YWHAZ/AKT Pathways.
Xie J; Guo T; Zhong Z; Wang N; Liang Y; Zeng W; Liu S; Chen Q; Tang X; Wu H; Zhang S; Ma K; Wang B; Ou Y; Gu W; Chen H; Qiu Y; Duan Y
Front Cell Dev Biol; 2021; 9():711149. PubMed ID: 34977001
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological Features and Prognostic Evaluation of UBR5 in Liver Cancer Patients.
Huo Q; Hu J; Hou B; Zhao M; Han X; Du Y; Li Y
Pathol Oncol Res; 2022; 28():1610396. PubMed ID: 36388433
[No Abstract] [Full Text] [Related]
[Next] [New Search]